AAAAAA

   
Results: 1-9 |
Results: 9
The potential of TRAIL for cancer chemotherapy
Authors: Nagane, M Huang, HJS Cavenee, WK
Citation: M. Nagane et al., The potential of TRAIL for cancer chemotherapy, APOPTOSIS, 6(3), 2001, pp. 191-197
Inhibitory effects of sodium butyrate on proliferation and invasiveness ofhuman glioma cells
Authors: Ito, N Sawa, H Nagane, M Noguchi, A Hara, M Saito, I
Citation: N. Ito et al., Inhibitory effects of sodium butyrate on proliferation and invasiveness ofhuman glioma cells, NEUROSURGER, 49(2), 2001, pp. 430-436
Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor
Authors: Nagane, M Narita, Y Mishima, K Levitzki, A Burgess, AW Cavenee, WK Huang, HJS
Citation: M. Nagane et al., Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitor, J NEUROSURG, 95(3), 2001, pp. 472-479
Vascular endothelial growth factor isoforms display distinct activities inpromoting tumor angiogenesis at different anatomic sites
Authors: Guo, P Xu, L Pan, S Brekken, RA Yang, ST Whitaker, GB Nagane, M Thorpe, PE Rosenbaum, JS Huang, HJS Cavenee, WK Cheng, SY
Citation: P. Guo et al., Vascular endothelial growth factor isoforms display distinct activities inpromoting tumor angiogenesis at different anatomic sites, CANCER RES, 61(23), 2001, pp. 8569-8577
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
Authors: Nagane, M Pan, GH Weddle, JJ Dixit, VM Cavenee, WK Huang, HJS
Citation: M. Nagane et al., Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo, CANCER RES, 60(4), 2000, pp. 847-853
Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma
Authors: Nagane, M Huang, HJS Cavenee, WK
Citation: M. Nagane et al., Causes of drug resistance and novel therapeutic opportunities for the treatment of glioblastoma, DRUG RESIST, 2(1), 1999, pp. 30-37
Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro
Authors: Bogler, O Nagane, M Gillis, J Huang, HJS Cavenee, WK
Citation: O. Bogler et al., Malignant transformation of p53-deficient astrocytes is modulated by environmental cues in vitro, CELL GROWTH, 10(2), 1999, pp. 73-86
Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs
Authors: Nagane, M Asai, A Shibui, S Oyama, H Nomura, K Kuchino, Y
Citation: M. Nagane et al., Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs, JPN J CLIN, 29(11), 1999, pp. 527-534
The chromosome 10 monosomy common in human melanomas results from the lossof two separate tumor suppressor loci
Authors: Robertson, GP Herbst, RA Nagane, M Huang, HJS Cavenee, WK
Citation: Gp. Robertson et al., The chromosome 10 monosomy common in human melanomas results from the lossof two separate tumor suppressor loci, CANCER RES, 59(15), 1999, pp. 3596-3601
Risultati: 1-9 |